Fusion Pharmaceuticals Inc. Stock Split Ratio
Fusion Pharmaceuticals Inc. had Stock Split Ratio of 18.70% as of 2020-06-19, per its 10-K filed 2022-03-17.
Discontinued › Notes
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-03-17
- 2020-06-19: Stockholders' Equity Note, Stock Split, Conversion Ratio 18.70%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2020-06-19 | 18.70% 10-K · filed 2022-03-17 |